Back to tech
tech

Medtech Trends Shaping Global Markets: From VBP to Platform Competition

An analysis of key medical technology trends in 2026, including China's VBP expansion, the shift to outpatient settings, supply chain resilience, and the impact of GLP-1 therapies on patient care pathways.

IP
The IntlPost EditorialPublished October 27, 2026
Medtech Trends Shaping Global Markets: From VBP to Platform Competition
  • The medical technology landscape is entering a period of accelerated change, characterized by structural shifts across global pricing, care delivery, supply chains, clinical pathways, and enabling technologies. Structural forces are currently redefining how companies compete and where growth will materialize.
  • Mainland China’s Volume-Based Procurement (VBP) expansion is a primary driver. This mechanism is evolving beyond simple access expansion into a sophisticated market-structuring tool, introducing complex anchor-price logic and allocation systems that significantly influence global medtech pricing expectations and domestic manufacturing portfolios.
  • A notable shift in care delivery is the migration of procedures from traditional hospital settings to outpatient and Ambulatory Surgical Center (ASC) environments. Regulatory updates, such as those from the U.S. Centers for Medicare & Medicaid Services (CMS), are reinforcing this trend by expanding eligible procedure lists, allowing for the deployment of higher-acuity procedures in lower-cost settings.
  • Global trade and supply chain pressures are forcing manufacturers to fundamentally reassess their operational footprints. Geopolitical factors, tariffs, and material cost volatility are compelling companies to diversify sourcing and adopt flexible, multi-region manufacturing strategies to mitigate exposure.
  • The adoption of GLP-1 therapies is significantly altering patient behavior and clinical care pathways. The rapid uptake of these drugs is creating ripple effects across adjacent medtech categories, influencing referral patterns and demanding new considerations for cardiovascular monitoring and diabetes management devices.
  • Enabling technologies, such as robotics, advanced imaging, and digital workflow software, are moving from supplementary tools to central components of clinical ecosystems. This shift is fueling a trend toward platform-based competition, where integrated systems provide a more robust value proposition for companies.
  • The convergence of these trends suggests that future success in the medtech industry will depend not just on product performance but on strategic agility in navigating complex regulatory frameworks, optimizing supply chain resilience, and building integrated technology platforms.
Topics:
tech